Previous studies have indicated that cell motility can be enhanced through Akt activation under acidic conditions [7,17], and that gallic acid can inhibit cancer cell growth and malignancy by controlling Akt in various cancer types, such as bladder cancer and myeloid leukemia [9,18,19,20]. The gene discussed is AKT1; the disease is urinary bladder cancer.